首页 > 最新文献

Actas urologicas espanolas最新文献

英文 中文
Masa renal secundaria a la enfermedad de Rosai-Dorfman: reporte de caso clínico Rosai-Dorfman病继发性肾肿块:临床病例报告
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.acuro.2025.501750
A. Romero Crespo , R. España Navarro , E. Prieto Sanchez , E. Garcia Galisteo
{"title":"Masa renal secundaria a la enfermedad de Rosai-Dorfman: reporte de caso clínico","authors":"A. Romero Crespo , R. España Navarro , E. Prieto Sanchez , E. Garcia Galisteo","doi":"10.1016/j.acuro.2025.501750","DOIUrl":"10.1016/j.acuro.2025.501750","url":null,"abstract":"","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 1","pages":"Article 501750"},"PeriodicalIF":1.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145898169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Perspectiva internacional sobre el diagnóstico y tratamiento de la enuresis nocturna: estudio basado en una encuesta del Grupo de Trabajo de Urología Pediátrica de la Sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU) 夜尿症诊断和治疗的国际视角:基于欧洲泌尿学协会青年泌尿科(YAU)儿科泌尿学工作组的调查研究
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.acuro.2025.501822
N. Baydilli , M.İ. Dönmez , Y. Quiroz Madarriaga , B. Banuelos Marco , İ. Selvi , E. Bindi , R. Lammers , S. Sforza , L.A. ’tHoen , en representación del Grupo de Trabajo de Urología Pediátrica de la Sección de Jóvenes Urólogos Académicos – Asociación Europea de Urología (EAU-YAU)

Objective

This study assessed global diagnostic and therapeutic approaches to nocturnal enuresis (NE), highlighting current practices and variations.

Materials and methods

An 18-question survey by the European Association of Urology (EAU) Young Academic Urologist (YAU) Paediatric Urology Working Group targeted clinicians managing NE. Distributed online, it reached Urologists, Pediatric Urologists, Pediatricians, Nephrologists, and Urotherapists. The survey collected demographic data and details on diagnostic and treatment practices. Responses were analyzed using descriptive statistics.

Results

Most respondents worked in university or government hospitals, with pediatric urologists forming the largest group (43.6%). A significant portion had 11-20 years of NE management experience. Initial treatment favored behavioral strategies and urotherapy (84.5%), with desmopressin as a common first-line medication (23.8%). Most clinicians initiated treatment at ages 5-6. Bladder diaries were widely used (82.0%), while airway assessments were inconsistent (52.1%). Diagnostic test usage varied, with urinary tract ultrasonography (53.65%) and urinalysis (51.5%) employed to identify underlying abnormalities. Psychological referrals were common for secondary enuresis (58.9%).

Conclusion

NE management varies globally due to regional practices, clinician experience, and specialty focus. The findings emphasize the need for standardized guidelines and education on comprehensive assessments, including sleep-related factors. International collaboration and guideline development could enhance consistency and improve patient outcomes.
目的:本研究评估了全球夜间遗尿症(NE)的诊断和治疗方法,强调了当前的做法和变化。材料和方法欧洲泌尿外科协会(EAU)青年学术泌尿科医师(YAU)儿科泌尿外科工作组针对临床医生进行了一项18个问题的调查。在网上分发,它到达泌尿科医生、儿科泌尿科医生、儿科医生、肾病科医生和泌尿治疗师。该调查收集了人口统计数据以及诊断和治疗实践的细节。采用描述性统计对反馈进行分析。结果大多数受访医师在大学或公立医院工作,其中儿科泌尿科医师占43.6%。相当一部分人有11-20年的网络资源管理经验。初始治疗倾向于行为策略和泌尿治疗(84.5%),去氨加压素作为常见的一线药物(23.8%)。大多数临床医生在5-6岁时开始治疗。膀胱日记被广泛使用(82.0%),而气道评估不一致(52.1%)。诊断检查的使用各不相同,使用尿路超声检查(53.65%)和尿液分析(51.5%)来识别潜在的异常。继发性遗尿常见心理转诊(58.9%)。结论:由于地区实践、临床医生经验和专业重点的不同,ne的管理在全球范围内存在差异。研究结果强调了对包括睡眠相关因素在内的综合评估进行标准化指导和教育的必要性。国际合作和指南的制定可以增强一致性并改善患者的预后。
{"title":"Perspectiva internacional sobre el diagnóstico y tratamiento de la enuresis nocturna: estudio basado en una encuesta del Grupo de Trabajo de Urología Pediátrica de la Sección de Jóvenes Urólogos Académicos (YAU) de la Asociación Europea de Urología (EAU)","authors":"N. Baydilli ,&nbsp;M.İ. Dönmez ,&nbsp;Y. Quiroz Madarriaga ,&nbsp;B. Banuelos Marco ,&nbsp;İ. Selvi ,&nbsp;E. Bindi ,&nbsp;R. Lammers ,&nbsp;S. Sforza ,&nbsp;L.A. ’tHoen ,&nbsp;en representación del Grupo de Trabajo de Urología Pediátrica de la Sección de Jóvenes Urólogos Académicos – Asociación Europea de Urología (EAU-YAU)","doi":"10.1016/j.acuro.2025.501822","DOIUrl":"10.1016/j.acuro.2025.501822","url":null,"abstract":"<div><h3>Objective</h3><div>This study assessed global diagnostic and therapeutic approaches to nocturnal enuresis (NE), highlighting current practices and variations.</div></div><div><h3>Materials and methods</h3><div>An 18-question survey by the European Association of Urology (EAU) Young Academic Urologist (YAU) Paediatric Urology Working Group targeted clinicians managing NE. Distributed online, it reached Urologists, Pediatric Urologists, Pediatricians, Nephrologists, and Urotherapists. The survey collected demographic data and details on diagnostic and treatment practices. Responses were analyzed using descriptive statistics.</div></div><div><h3>Results</h3><div>Most respondents worked in university or government hospitals, with pediatric urologists forming the largest group (43.6%). A significant portion had 11-20 years of NE management experience. Initial treatment favored behavioral strategies and urotherapy (84.5%), with desmopressin as a common first-line medication (23.8%). Most clinicians initiated treatment at ages 5-6. Bladder diaries were widely used (82.0%), while airway assessments were inconsistent (52.1%). Diagnostic test usage varied, with urinary tract ultrasonography (53.65%) and urinalysis (51.5%) employed to identify underlying abnormalities. Psychological referrals were common for secondary enuresis (58.9%).</div></div><div><h3>Conclusion</h3><div>NE management varies globally due to regional practices, clinician experience, and specialty focus. The findings emphasize the need for standardized guidelines and education on comprehensive assessments, including sleep-related factors. International collaboration and guideline development could enhance consistency and improve patient outcomes.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 1","pages":"Article 501822"},"PeriodicalIF":1.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145898161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluación de la eficacia del tratamiento según los criterios RECIP 1.0 en el cáncer de próstata sensible a la castración 根据RECIP 1.0标准评估阉割敏感前列腺癌的治疗效果
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.acuro.2025.501837
I. Gulturk , C. Kapar , E. Arslan , M. Polat , G.B. Sonmezoz , D. Tural

Objective

To evaluate the relationship between treatment response and radiological progression-free survival (rPFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC) assessed by PSMA-PET/CT using Response Evaluation Criteria on PSMA (RECIP 1.0) criteria.

Methods

In this study, 116 patients were analyzed retrospectively. At the beginning of the treatment and week 12 were PSMA PET/CT images evaluated for changes in total tumor volüme and new lesions. Patients were divided into four groups according to RECIP criteria; complete response (CR), partial response (PR), stable disease (SD) and progressive disease (PD). The primary outcome was the correlation of RECIP criteria with rPFS.

Results

Mean age of the patients was 67 years (IQR: 62-72]). Total of 116 patients; 65 (56%) had PR, 17 (14,6%) SD, 19 (16,3%) PD, and 15 (12%) CR. rPFS was found to be statistically significantly different among these four groups (P<.001). RECIP PD was found to be significantly shorter rPFS compared with non-PD (P<.001), with an rPFS of 7 months (95% CI: 3.45-10.56). PSA values were measured at nadir in 40 patients and no patient in this group was evaluated as having PD.

Conclusion

RECIP criteria have been shown to have prognostic significance in terms of evaluating treatment response and rPFS in mCSPC patients.
目的应用PSMA反应评价标准(RECIP 1.0)评价PSMA- pet /CT评估转移性去雄敏感前列腺癌(mCSPC)患者治疗反应与放射学无进展生存期(rPFS)的关系。方法回顾性分析116例患者的临床资料。在治疗开始和第12周时,评估PSMA PET/CT图像,以评估总肿瘤体积和新病变的变化。根据RECIP标准将患者分为4组;完全缓解(CR)、部分缓解(PR)、病情稳定(SD)和病情进展(PD)。主要结局是RECIP标准与rPFS的相关性。结果患者平均年龄67岁(IQR: 62 ~ 72)。116例患者;PR 65例(56%),SD 17例(14.6%),PD 19例(16.3%),cr 15例(12%)。四组间rPFS差异有统计学意义(p < 0.01)。与非PD相比,RECIP PD的rPFS明显缩短(P<.001), rPFS为7个月(95% CI: 3.45-10.56)。40例患者的PSA值在最低点测量,该组中没有患者被评估为PD。结论recip标准在评估mCSPC患者的治疗反应和rPFS方面具有预后意义。
{"title":"Evaluación de la eficacia del tratamiento según los criterios RECIP 1.0 en el cáncer de próstata sensible a la castración","authors":"I. Gulturk ,&nbsp;C. Kapar ,&nbsp;E. Arslan ,&nbsp;M. Polat ,&nbsp;G.B. Sonmezoz ,&nbsp;D. Tural","doi":"10.1016/j.acuro.2025.501837","DOIUrl":"10.1016/j.acuro.2025.501837","url":null,"abstract":"<div><h3>Objective</h3><div>To evaluate the relationship between treatment response and radiological progression-free survival (rPFS) in patients with metastatic castration-sensitive prostate cancer (mCSPC) assessed by PSMA-PET/CT using Response Evaluation Criteria on PSMA (RECIP 1.0) criteria.</div></div><div><h3>Methods</h3><div>In this study, 116 patients were analyzed retrospectively. At the beginning of the treatment and week 12 were PSMA PET/CT images evaluated for changes in total tumor volüme and new lesions. Patients were divided into four groups according to RECIP criteria; complete response (CR), partial response (PR), stable disease (SD) and progressive disease (PD). The primary outcome was the correlation of RECIP criteria with rPFS.</div></div><div><h3>Results</h3><div>Mean age of the patients was 67 years (IQR: 62-72]). Total of 116 patients; 65 (56%) had PR, 17 (14,6%) SD, 19 (16,3%) PD, and 15 (12%) CR. rPFS was found to be statistically significantly different among these four groups (<em>P</em>&lt;.001). RECIP PD was found to be significantly shorter rPFS compared with non-PD (<em>P</em>&lt;.001), with an rPFS of 7 months (95% CI: 3.45-10.56). PSA values were measured at nadir in 40 patients and no patient in this group was evaluated as having PD.</div></div><div><h3>Conclusion</h3><div>RECIP criteria have been shown to have prognostic significance in terms of evaluating treatment response and rPFS in mCSPC patients.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 1","pages":"Article 501837"},"PeriodicalIF":1.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145898165","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heminefroureterectomía laparoscópica en riñón en herradura con sospecha de carcinoma urotelial empleando un modelo virtual 3 D de hiperprecisión 使用超精密3D虚拟模型对疑似输尿管癌的马蹄患者进行腹腔镜肾半输尿管切除术
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2026-01-01 DOI: 10.1016/j.acuro.2025.501747
A. Garcia-Segui, M. Ferrández-Jimenez, N. García-Cárceles, C. Soler-López
{"title":"Heminefroureterectomía laparoscópica en riñón en herradura con sospecha de carcinoma urotelial empleando un modelo virtual 3 D de hiperprecisión","authors":"A. Garcia-Segui,&nbsp;M. Ferrández-Jimenez,&nbsp;N. García-Cárceles,&nbsp;C. Soler-López","doi":"10.1016/j.acuro.2025.501747","DOIUrl":"10.1016/j.acuro.2025.501747","url":null,"abstract":"","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"50 1","pages":"Article 501747"},"PeriodicalIF":1.2,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145898168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manejo de la incontinencia tras el cierre de la extrofia vesical clásica 经典膀胱外损闭合后失禁的管理
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.acuro.2025.501818
K. Godlewski, M. Davis, D. Weiss, A. Shukla

Introduction

Classic bladder exstrophy presents a unique challenge for reconstructive surgeons given the significant alternations it has on normal pelvic anatomy. The ultimate goal of surgery, whether in one stage or more, is simple; close the bladder, reconstruct the bladder neck and urethra, and place the unit into a more orthotopic position deep in the pelvis, and establish normal genitalia. Despite significant improvements with the success of bladder exstrophy closure, a patient's ability to volitionally void and achieve urinary continence after initial closure remain an elusive «holy grail» for bladder exstrophy surgeons. After closure many patients will endure persistent urinary incontinence post exstrophy closure. In this review, we will discuss the conservative strategies and surgical options to facilitate continence in our bladder exstrophy patients. Regardless of surgical approach or initial outcome, all patients with bladder exstrophy require lifelong urologic follow-up.

Methods

A comprehensive search of electronic databases (Medline, PubMed, Embase, PsycINFO and CINAHL), and citation tracking platforms (Google Scholar and Web of Science) was performed. Keywords included classic bladder exstrophy, incontinence, behavioral therapy, urotherapy, biofeedback, bulking agents, artificial urinary sphincter, bladder neck reconstruction, bladder neck closure, urinary diversion.

Results

Conservative measures such as behavioral therapy, physical therapy and uropsychological counseling should be first line for the treatment of urinary incontinence after exstrophy closure. These interventions along with maturation of the child and bladder growth can improve incontinence without surgery. Patients should be counseled on the limited success of bulking agents and significant risk of erosion with sphincters. Although success after bladder neck reconstruction or bladder neck closure with or without augmentation and catheterizable channel can be variable, these surgical options can be offered to patients that have exhausted conservative treatment strategies.

Conclusions

A patient's ability to volitionally void and achieve urinary continence remain an elusive goal for bladder exstrophy surgeons with many experiencing persistent urinary incontinence following exstrophy closure. Behavioral therapy, physical therapy and pyschological support should be provided to all bladder exstrophy patients and families. Giving children time to grow and mature can potentially facilitate continence without surgical intervention. If surgical intervention is pursued lifelong follow-up and monitoring is critical.
经典膀胱外翻对重建外科医生提出了一个独特的挑战,因为它对正常骨盆解剖结构有重大的改变。手术的最终目的,无论是一个阶段还是多个阶段,都很简单;关闭膀胱,重建膀胱颈和尿道,并将单元置于骨盆深处更正位的位置,并建立正常的生殖器。尽管膀胱外翻闭合术的成功取得了显著的进步,但对于膀胱外翻外科医生来说,患者在初次闭合后自愿排空并实现尿失禁的能力仍然是一个难以实现的“圣杯”。闭锁后,许多患者在闭锁后会出现持续性尿失禁。在这篇综述中,我们将讨论保守策略和手术选择,以促进膀胱外翻患者的自制。无论采用何种手术方式或初始结果,所有膀胱外翻患者都需要终身泌尿外科随访。方法综合检索电子数据库(Medline、PubMed、Embase、PsycINFO和CINAHL)和引文跟踪平台(b谷歌Scholar和Web of Science)。关键词:经典膀胱外翻,尿失禁,行为治疗,泌尿治疗,生物反馈,膨胀剂,人工尿括约肌,膀胱颈重建,膀胱颈闭合,尿分流。结果行为治疗、物理治疗、泌尿心理咨询等保守措施是治疗外翻术后尿失禁的首选方法。随着儿童的成熟和膀胱的生长,这些干预措施可以改善失禁而无需手术。应告知患者膨胀剂的有限成功和括约肌糜烂的重大风险。尽管膀胱颈重建术或膀胱颈闭合术的成功与否有不同,但这些手术选择可以提供给已经用尽保守治疗策略的患者。结论膀胱外翻术后患者能否自主排尿并实现尿失禁一直是膀胱外翻外科医生难以实现的目标,许多患者在膀胱外翻术后出现了持续性尿失禁。对膀胱外翻患者及其家属应给予行为治疗、物理治疗和心理支持。给孩子时间成长和成熟可以潜在地促进失禁,而无需手术干预。如果进行手术干预,终身随访和监测是至关重要的。
{"title":"Manejo de la incontinencia tras el cierre de la extrofia vesical clásica","authors":"K. Godlewski,&nbsp;M. Davis,&nbsp;D. Weiss,&nbsp;A. Shukla","doi":"10.1016/j.acuro.2025.501818","DOIUrl":"10.1016/j.acuro.2025.501818","url":null,"abstract":"<div><h3>Introduction</h3><div>Classic bladder exstrophy presents a unique challenge for reconstructive surgeons given the significant alternations it has on normal pelvic anatomy. The ultimate goal of surgery, whether in one stage or more, is simple; close the bladder, reconstruct the bladder neck and urethra, and place the unit into a more orthotopic position deep in the pelvis, and establish normal genitalia. Despite significant improvements with the success of bladder exstrophy closure, a patient's ability to volitionally void and achieve urinary continence after initial closure remain an elusive «holy grail» for bladder exstrophy surgeons. After closure many patients will endure persistent urinary incontinence post exstrophy closure. In this review, we will discuss the conservative strategies and surgical options to facilitate continence in our bladder exstrophy patients. Regardless of surgical approach or initial outcome, all patients with bladder exstrophy require lifelong urologic follow-up.</div></div><div><h3>Methods</h3><div>A comprehensive search of electronic databases (Medline, PubMed, Embase, PsycINFO and CINAHL), and citation tracking platforms (Google Scholar and Web of Science) was performed. Keywords included classic bladder exstrophy, incontinence, behavioral therapy, urotherapy, biofeedback, bulking agents, artificial urinary sphincter, bladder neck reconstruction, bladder neck closure, urinary diversion.</div></div><div><h3>Results</h3><div>Conservative measures such as behavioral therapy, physical therapy and uropsychological counseling should be first line for the treatment of urinary incontinence after exstrophy closure. These interventions along with maturation of the child and bladder growth can improve incontinence without surgery. Patients should be counseled on the limited success of bulking agents and significant risk of erosion with sphincters. Although success after bladder neck reconstruction or bladder neck closure with or without augmentation and catheterizable channel can be variable, these surgical options can be offered to patients that have exhausted conservative treatment strategies.</div></div><div><h3>Conclusions</h3><div>A patient's ability to volitionally void and achieve urinary continence remain an elusive goal for bladder exstrophy surgeons with many experiencing persistent urinary incontinence following exstrophy closure. Behavioral therapy, physical therapy and pyschological support should be provided to all bladder exstrophy patients and families. Giving children time to grow and mature can potentially facilitate continence without surgical intervention. If surgical intervention is pursued lifelong follow-up and monitoring is critical.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"49 10","pages":"Article 501818"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Terapia hormonal para el testículo no descendido: resultados de un cuestionario internacional 睾丸激素治疗:国际问卷调查结果
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.acuro.2025.501820
R.J.M. Lammers , L.A.’t Hoen , F. O’Kelly , I. Selvi , Y. Quiroz Madarriaga , N. Baydilli , B. Bañuelos Marco , M.I. Dönmez , S. Sforza , E. Bindi , B. Haid , en representación del Grupo de Trabajo de Urología Pediátrica de la Sección de Jóvenes Urólogos Académicos (YAU) - Asociación Europea de Urología (EAU)
The objective of this study was to provide an overview of current practices on hormonal therapy (HT) in children with undescended testes (UDT).
An online questionnaire about HT, referral patterns, and orchidopexy was spread via several (social media) networks involved in pediatric urology.
A total of 283 individuals responded, with 54 countries sampled. The majority (84%) did not prescribe HT for UDT, predominantly due to a paucity of scientific evidence (76%). Among those who use HT, main reason was bilateral UDT (62%). There was no clear preference in administration type (50% intramuscular injection, 50% nasal spray). GnRH was slightly more favoured over HCG (50% vs. 32%). No standardized schedule was used. Most respondents (67%) felt all forms of UDT should be treated by either a pediatric urologist or -surgeon. Eighty-seven percent follow the current guidelines and perform orchidopexy between 6-18 months of age.
本研究的目的是提供一个概述目前的做法激素治疗(HT)的儿童睾丸隐睾(UDT)。一份关于HT、转诊模式和睾丸切除术的在线问卷通过涉及儿科泌尿外科的几个(社交媒体)网络传播。在54个国家,共有283人做出了回应。大多数(84%)没有为UDT开HT,主要是由于缺乏科学证据(76%)。在使用HT的患者中,主要原因是双侧UDT(62%)。给药方式没有明显的偏好(50%肌内注射,50%鼻喷)。GnRH比HCG更受青睐(50%对32%)。没有使用标准化的时间表。大多数应答者(67%)认为所有形式的UDT都应该由儿科泌尿科医生或外科医生进行治疗。87%的人遵循目前的指导方针,在6-18个月大的时候进行兰花切除术。
{"title":"Terapia hormonal para el testículo no descendido: resultados de un cuestionario internacional","authors":"R.J.M. Lammers ,&nbsp;L.A.’t Hoen ,&nbsp;F. O’Kelly ,&nbsp;I. Selvi ,&nbsp;Y. Quiroz Madarriaga ,&nbsp;N. Baydilli ,&nbsp;B. Bañuelos Marco ,&nbsp;M.I. Dönmez ,&nbsp;S. Sforza ,&nbsp;E. Bindi ,&nbsp;B. Haid ,&nbsp;en representación del Grupo de Trabajo de Urología Pediátrica de la Sección de Jóvenes Urólogos Académicos (YAU) - Asociación Europea de Urología (EAU)","doi":"10.1016/j.acuro.2025.501820","DOIUrl":"10.1016/j.acuro.2025.501820","url":null,"abstract":"<div><div>The objective of this study was to provide an overview of current practices on hormonal therapy (HT) in children with undescended testes (UDT).</div><div>An online questionnaire about HT, referral patterns, and orchidopexy was spread via several (social media) networks involved in pediatric urology.</div><div>A total of 283 individuals responded, with 54 countries sampled. The majority (84%) did not prescribe HT for UDT, predominantly due to a paucity of scientific evidence (76%). Among those who use HT, main reason was bilateral UDT (62%). There was no clear preference in administration type (50% intramuscular injection, 50% nasal spray). GnRH was slightly more favoured over HCG (50% vs. 32%). No standardized schedule was used. Most respondents (67%) felt all forms of UDT should be treated by either a pediatric urologist or -surgeon. Eighty-seven percent follow the current guidelines and perform orchidopexy between 6-18 months of age.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"49 10","pages":"Article 501820"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasonido focalizado de alta intensidad con el dispositivo Focal One para el cáncer de próstata localizado: revisión sistemática de resultados oncológicos, preservación funcional y evolución de la tecnología 使用Focal One设备对局部前列腺癌进行高强度聚焦超声:系统检查肿瘤结果、功能保存和技术发展
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.acuro.2025.501869
K. Eskandar

Introduction

Focal therapy offers a middle-ground approach for localized prostate cancer, preserving the prostate while avoiding the morbidity of radical treatment. High-Intensity Focused Ultrasound (HIFU) is the most studied focal modality, with FocalONE representing the most widely adopted modern platform enabling precise image-guided ablation.

Objective

To systematically assess the oncologic control, functional outcomes, safety, and technological advancements of focal and hemiablation HIFU with an emphasis on the FocalONE platform.

Methodology

This systematic review followed PRISMA guidelines and was registered in PROSPERO. A comprehensive search of PubMed, Embase, and Cochrane databases identified prospective studies using FocalONE or earlier-generation transrectal HIFU devices for focal or hemiablation in localized prostate cancer. Key outcomes included biopsy negativity, salvage-free survival, urinary continence, erectile function, and complications. Study quality was appraised using the JBI tool.

Results

Five prospective studies involving 701 patients were included. Biopsy negativity ranged from 84% to 95%, with salvage-free survival reaching up to 92% at mid-term follow-up. Urinary continence was preserved in 96–100% of patients, and erectile function in 74–95%, with the most favorable functional outcomes consistently observed in FocalONE-based cohorts. Most adverse events were minor (grade I–II), with few serious complications. Compared to focal cryotherapy and irreversible electroporation, HIFU showed comparable cancer control and better or similar functional preservation. PSA density and MRI-visible lesions were strong predictors of success.

Conclusions

FocalONE-based focal HIFU provides effective cancer control with excellent functional preservation in selected patients. While evidence from earlier-generation devices supports these trends, generalizability across all HIFU platforms remains to be validated. Its precision and safety profile make it a promising alternative between active surveillance and radical therapies, especially in favorable intermediate-risk cases.
局灶性治疗为局部前列腺癌提供了一种中间方法,既保留了前列腺,又避免了根治性治疗的发病率。高强度聚焦超声(HIFU)是研究最多的聚焦方式,FocalONE代表了最广泛采用的现代平台,可以实现精确的图像引导消融。目的系统评价聚焦和半消融HIFU的肿瘤控制、功能结局、安全性和技术进步,重点评价FocalONE平台。方法:本系统综述遵循PRISMA指南,并在PROSPERO注册。PubMed、Embase和Cochrane数据库的综合检索确定了使用FocalONE或早期经直肠HIFU设备治疗局限性前列腺癌局灶性或半消融的前瞻性研究。主要结局包括活检阴性、无抢救生存、尿失禁、勃起功能和并发症。采用JBI工具评价研究质量。结果纳入5项前瞻性研究,涉及701例患者。活检阴性范围为84%至95%,中期随访时无打捞生存率高达92%。96-100%的患者保留了尿失禁,74-95%的患者保留了勃起功能,在以福卡龙为基础的队列中观察到最有利的功能结果。大多数不良事件轻微(I-II级),很少有严重并发症。与局部冷冻治疗和不可逆电穿孔相比,HIFU显示出相当的癌症控制和更好或相似的功能保存。PSA密度和mri可见病变是成功的有力预测指标。结论以focalone为基础的局灶HIFU对部分患者具有良好的功能保存和有效的肿瘤控制作用。虽然来自早期设备的证据支持这些趋势,但所有HIFU平台的普遍性仍有待验证。其准确性和安全性使其成为主动监测和根治性治疗之间的一个有希望的替代方案,特别是在有利的中等风险病例中。
{"title":"Ultrasonido focalizado de alta intensidad con el dispositivo Focal One para el cáncer de próstata localizado: revisión sistemática de resultados oncológicos, preservación funcional y evolución de la tecnología","authors":"K. Eskandar","doi":"10.1016/j.acuro.2025.501869","DOIUrl":"10.1016/j.acuro.2025.501869","url":null,"abstract":"<div><h3>Introduction</h3><div>Focal therapy offers a middle-ground approach for localized prostate cancer, preserving the prostate while avoiding the morbidity of radical treatment. High-Intensity Focused Ultrasound (HIFU) is the most studied focal modality, with FocalONE representing the most widely adopted modern platform enabling precise image-guided ablation.</div></div><div><h3>Objective</h3><div>To systematically assess the oncologic control, functional outcomes, safety, and technological advancements of focal and hemiablation HIFU with an emphasis on the FocalONE platform.</div></div><div><h3>Methodology</h3><div>This systematic review followed PRISMA guidelines and was registered in PROSPERO. A comprehensive search of PubMed, Embase, and Cochrane databases identified prospective studies using FocalONE or earlier-generation transrectal HIFU devices for focal or hemiablation in localized prostate cancer. Key outcomes included biopsy negativity, salvage-free survival, urinary continence, erectile function, and complications. Study quality was appraised using the JBI tool.</div></div><div><h3>Results</h3><div>Five prospective studies involving 701 patients were included. Biopsy negativity ranged from 84% to 95%, with salvage-free survival reaching up to 92% at mid-term follow-up. Urinary continence was preserved in 96–100% of patients, and erectile function in 74–95%, with the most favorable functional outcomes consistently observed in FocalONE-based cohorts. Most adverse events were minor (grade I–II), with few serious complications. Compared to focal cryotherapy and irreversible electroporation, HIFU showed comparable cancer control and better or similar functional preservation. PSA density and MRI-visible lesions were strong predictors of success.</div></div><div><h3>Conclusions</h3><div>FocalONE-based focal HIFU provides effective cancer control with excellent functional preservation in selected patients. While evidence from earlier-generation devices supports these trends, generalizability across all HIFU platforms remains to be validated. Its precision and safety profile make it a promising alternative between active surveillance and radical therapies, especially in favorable intermediate-risk cases.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"49 10","pages":"Article 501869"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparación entre la biopsia prostática dirigida por fusión cognitiva y la biopsia estándar después de resonancia magnética multiparamétrica de próstata (RMmp) y valor diagnóstico de RMmp 认知融合前列腺活检与前列腺多参数核磁共振(MRMp)和诊断MRMp后标准活检的比较
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.acuro.2025.501839
Ö. Faruk Akgün , A. Altunkol , E. Alma , Ü. Uysal , B. Aksay , Y.E. Kök

Objectives

To compare the diagnostic performance of cognitive fusion biopsy and/or standard systematic biopsy performed following multiparametric magnetic resonance imaging (mpMRI) in the detection of prostate cancer (PCa), and to assess the standalone diagnostic value of mpMRI.

Materials and methods

Initially, 1153 patients undergoing PBx from 2017 to 2022 were chosen. Patients were divided into three groups: those with standard PBx without mpMRI (1 st group), those with standard PBx after mpMRI (2 nd group) and those with standard and cognitive fusion PBx after mpMRI (3 rd group). The correlations of general PCa and clinically significant PCa (csPCa) detection rates and Prostate Imaging Reporting and Data System version 2.1 (PI-RADS v2.1) scores were evaluated.

Results

The overall PCa detection rate was highest in group 2 (47%). Additionally, the malignancy rate in group 3 was significantly higher compared to group 1 (p< 0.05). Though the csPCa rate was higher in the third group (40%) compared to the other groups, no significant difference was identified. As the PI-RADS score increased, the malignancy rates appeared to increase. The rate of high-risk patients in the group with cognitive fusion biopsy performed (11, 17%) was higher compared to the second group (p< 0.05).

Conclusions

Multiparametric MRI is valuable in prostate cancer diagnosis, particularly for lesion detection and biopsy guidance in patients with high PI-RADS scores. However, in our study, the addition of cognitive fusion biopsy did not significantly increase the detection rate of csPCa. Further prospective randomized studies are needed to clarify its diagnostic value.
目的比较多参数磁共振成像(mpMRI)后进行认知融合活检和/或标准系统活检对前列腺癌(PCa)的诊断效果,并评估mpMRI单独诊断的价值。材料和方法首先选择2017年至2022年接受PBx治疗的1153例患者。患者分为三组:标准PBx不经mpMRI(第一组)、标准PBx经mpMRI(第二组)和标准PBx经mpMRI与认知融合(第三组)。评估一般前列腺癌和临床显著性前列腺癌(csPCa)检出率与前列腺影像学报告和数据系统2.1版(PI-RADS v2.1)评分的相关性。结果2组总前列腺癌检出率最高(47%)。3组的恶性肿瘤发生率显著高于1组(p < 0.05)。虽然第三组的csPCa发生率(40%)高于其他组,但没有发现显著差异。随着PI-RADS评分的增加,恶性肿瘤的发生率也随之增加。认知融合活检组高危患者的比例(11.17%)高于第二组(p < 0.05)。结论多参数MRI对前列腺癌的诊断具有重要价值,尤其对PI-RADS评分高的患者的病变检测和活检指导具有重要价值。然而,在我们的研究中,认知融合活检的加入并没有显著提高csPCa的检出率。需要进一步的前瞻性随机研究来阐明其诊断价值。
{"title":"Comparación entre la biopsia prostática dirigida por fusión cognitiva y la biopsia estándar después de resonancia magnética multiparamétrica de próstata (RMmp) y valor diagnóstico de RMmp","authors":"Ö. Faruk Akgün ,&nbsp;A. Altunkol ,&nbsp;E. Alma ,&nbsp;Ü. Uysal ,&nbsp;B. Aksay ,&nbsp;Y.E. Kök","doi":"10.1016/j.acuro.2025.501839","DOIUrl":"10.1016/j.acuro.2025.501839","url":null,"abstract":"<div><h3>Objectives</h3><div>To compare the diagnostic performance of cognitive fusion biopsy and/or standard systematic biopsy performed following multiparametric magnetic resonance imaging (mpMRI) in the detection of prostate cancer (PCa), and to assess the standalone diagnostic value of mpMRI.</div></div><div><h3>Materials and methods</h3><div>Initially, 1153 patients undergoing PBx from 2017 to 2022 were chosen. Patients were divided into three groups: those with standard PBx without mpMRI (1<!--> <!-->st group), those with standard PBx after mpMRI (2<!--> <!-->nd group) and those with standard and cognitive fusion PBx after mpMRI (3<!--> <!-->rd group). The correlations of general PCa and clinically significant PCa (csPCa) detection rates and Prostate Imaging Reporting and Data System version 2.1 (PI-RADS v2.1) scores were evaluated.</div></div><div><h3>Results</h3><div>The overall PCa detection rate was highest in group 2 (47%). Additionally, the malignancy rate in group 3 was significantly higher compared to group 1 (p&lt;<!--> <!-->0.05). Though the csPCa rate was higher in the third group (40%) compared to the other groups, no significant difference was identified. As the PI-RADS score increased, the malignancy rates appeared to increase. The rate of high-risk patients in the group with cognitive fusion biopsy performed (11, 17%) was higher compared to the second group (p&lt;<!--> <!-->0.05).</div></div><div><h3>Conclusions</h3><div>Multiparametric MRI is valuable in prostate cancer diagnosis, particularly for lesion detection and biopsy guidance in patients with high PI-RADS scores. However, in our study, the addition of cognitive fusion biopsy did not significantly increase the detection rate of csPCa. Further prospective randomized studies are needed to clarify its diagnostic value.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"49 10","pages":"Article 501839"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resultados del tratamiento quirúrgico de quistes parauretrales grandes 大侧胸囊肿手术治疗结果
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.acuro.2025.501865
N. Kulchenko , G. Demyashkin , A. Mansur , A. Strachuk , E. Korovyakova , R. Frantsev , K. Neklyudov , A. Mirontsev , V. Rostovskaya , K. Silakov

Introduction

Paraurethral cysts are rare in females and are often incidental findings during routine medical examinations. To date, no standardized approach exists for the surgical management of large cysts, which tend to cause the most discomfort to patients.

Objective

To evaluate the effectiveness of surgical treatment for large paraurethral cysts through excision and laser vaporization.

Method

The study included 49 female patients diagnosed with paraurethral cysts larger than 4 cm in diameter. The patients were divided into 2 groups: group 1 (n = 26) underwent excision of the paraurethral cyst, and group 2 (n = 23) underwent laser vaporization. All patients were monitored throughout their hospitalization. The parameters assessed included operation time, the number and type of intraoperative complications, the duration of bladder catheterization, and the length of hospital stay.

Results

Laser vaporization was, on average, 8.6 min shorter than excision (p < 0.05), with a strong correlation between the surgical method and operation time (r = 0.70). Intraoperative complications (bleeding, urethral injury, cyst rupture) occurred 2.8 times less frequently in group 2 compared to group 1. The length of hospital stay was 1.3 days shorter following laser vaporization. The correlation between hospital stay duration and surgical method was moderate (r = 0.31).

Conclusions

Laser vaporization offers significant advantages for the treatment of large paraurethral cysts, including shorter operation time, fewer intraoperative complications, and a faster recovery period. Therefore, laser vaporization should be considered the treatment of choice for large paraurethral cysts.
尿道旁囊肿在女性中很少见,通常是在常规医学检查中偶然发现的。迄今为止,对于大囊肿的外科治疗尚无标准化的方法,而大囊肿往往会给患者带来最大的不适。目的探讨激光汽化术治疗尿道旁大囊肿的疗效。方法对49例经诊断为尿道旁囊肿直径大于4cm的女性患者进行分析。患者分为2组:1组(26例)行尿道旁囊肿切除术,2组(23例)行激光汽化。所有患者在住院期间均接受监测。评估的参数包括手术时间、术中并发症的数量和类型、膀胱导尿时间和住院时间。结果激光汽化术比切除术平均缩短8.6 min (p < 0.05),手术方式与手术时间有较强相关性(r = 0.70)。2组术中并发症(出血、尿道损伤、囊肿破裂)发生率比1组低2.8倍。激光汽化后住院时间缩短1.3 d。住院时间与手术方式的相关性为中等(r = 0.31)。结论激光汽化术治疗尿道旁大囊肿具有手术时间短、术中并发症少、恢复快等优点。因此,对于较大的尿道旁囊肿,应考虑激光汽化治疗的选择。
{"title":"Resultados del tratamiento quirúrgico de quistes parauretrales grandes","authors":"N. Kulchenko ,&nbsp;G. Demyashkin ,&nbsp;A. Mansur ,&nbsp;A. Strachuk ,&nbsp;E. Korovyakova ,&nbsp;R. Frantsev ,&nbsp;K. Neklyudov ,&nbsp;A. Mirontsev ,&nbsp;V. Rostovskaya ,&nbsp;K. Silakov","doi":"10.1016/j.acuro.2025.501865","DOIUrl":"10.1016/j.acuro.2025.501865","url":null,"abstract":"<div><h3>Introduction</h3><div>Paraurethral cysts are rare in females and are often incidental findings during routine medical examinations. To date, no standardized approach exists for the surgical management of large cysts, which tend to cause the most discomfort to patients.</div></div><div><h3>Objective</h3><div>To evaluate the effectiveness of surgical treatment for large paraurethral cysts through excision and laser vaporization.</div></div><div><h3>Method</h3><div>The study included 49 female patients diagnosed with paraurethral cysts larger than 4<!--> <!-->cm in diameter. The patients were divided into 2 groups: group 1 (n<!--> <!-->=<!--> <!-->26) underwent excision of the paraurethral cyst, and group 2 (n<!--> <!-->=<!--> <!-->23) underwent laser vaporization. All patients were monitored throughout their hospitalization. The parameters assessed included operation time, the number and type of intraoperative complications, the duration of bladder catheterization, and the length of hospital stay.</div></div><div><h3>Results</h3><div>Laser vaporization was, on average, 8.6<!--> <!-->min shorter than excision (p<!--> <!-->&lt;<!--> <!-->0.05), with a strong correlation between the surgical method and operation time (r<!--> <!-->=<!--> <!-->0.70). Intraoperative complications (bleeding, urethral injury, cyst rupture) occurred 2.8 times less frequently in group 2 compared to group 1. The length of hospital stay was 1.3 days shorter following laser vaporization. The correlation between hospital stay duration and surgical method was moderate (r<!--> <!-->=<!--> <!-->0.31).</div></div><div><h3>Conclusions</h3><div>Laser vaporization offers significant advantages for the treatment of large paraurethral cysts, including shorter operation time, fewer intraoperative complications, and a faster recovery period. Therefore, laser vaporization should be considered the treatment of choice for large paraurethral cysts.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"49 10","pages":"Article 501865"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Valor de la longitud de biopsia por unidad de volumen en la biopsia prostática 前列腺活检单位体积活检长度值
IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Pub Date : 2025-12-01 DOI: 10.1016/j.acuro.2025.501862
J. Tang , T. Wu , K. Zhang , Z. Wen

Introduction

Prostate cancer is a significant global health issue. Prostate biopsy remains the gold standard for diagnosis. However, the impact of biopsy tissue length on diagnostic performance remains controversial. This study investigates the relationship between biopsy tissue length and diagnostic efficacy, introducing a new parameter, “unit volume biopsy length”, to optimize clinical practice.

Methods

A retrospective analysis was conducted on the clinical data of 301 patients who underwent prostate biopsy. The biopsy tissue length and unit volume biopsy length were compared between patients with positive and negative results, and their impact on the detection rate of prostate cancer was analyzed to obtain the optimal threshold for unit volume biopsy length.

Results

Among the 301 patients, 130 (43.19%) had positive results, while 171 had negative results. The median unit volume biopsy length in the positive group was 0.39 cm/ml, which was significantly higher than that in the negative group (0.28 cm/ml; P<.05). When the unit volume biopsy length exceeded 0.39 cm/ml, the detection rate of prostate cancer significantly increased (OR: 2.879, 95% CI: 1.728-4.796), with positive rates of 58.58% and 32.94% in the groups above and below the threshold, respectively (P<.05).

Conclusion

Unit volume biopsy length significantly affects the detection rate of prostate cancer. It is recommended that at least 0.39 cm of biopsy tissue be obtained per milliliter of prostate tissue to ensure adequate screening.
前列腺癌是一个重大的全球健康问题。前列腺活检仍然是诊断的金标准。然而,活检组织长度对诊断性能的影响仍然存在争议。本研究探讨了活检组织长度与诊断效果的关系,引入了一个新的参数“单位体积活检长度”,以优化临床实践。方法回顾性分析301例前列腺活检患者的临床资料。比较阳性和阴性患者的活检组织长度和单位体积活检长度,分析其对前列腺癌检出率的影响,得出单位体积活检长度的最佳阈值。结果301例患者中,阳性130例(43.19%),阴性171例。阳性组单位体积活检长度中位数为0.39 cm/ml,显著高于阴性组(0.28 cm/ml; P< 0.05)。当单位体积活检长度超过0.39 cm/ml时,前列腺癌的检出率显著增加(OR: 2.879, 95% CI: 1.728-4.796),高于阈值组阳性率为58.58%,低于阈值组阳性率为32.94% (P< 0.05)。结论单位体积活检长度对前列腺癌的检出率有显著影响。建议每毫升前列腺组织至少有0.39厘米的活检组织,以确保充分的筛查。
{"title":"Valor de la longitud de biopsia por unidad de volumen en la biopsia prostática","authors":"J. Tang ,&nbsp;T. Wu ,&nbsp;K. Zhang ,&nbsp;Z. Wen","doi":"10.1016/j.acuro.2025.501862","DOIUrl":"10.1016/j.acuro.2025.501862","url":null,"abstract":"<div><h3>Introduction</h3><div>Prostate cancer is a significant global health issue. Prostate biopsy remains the gold standard for diagnosis. However, the impact of biopsy tissue length on diagnostic performance remains controversial. This study investigates the relationship between biopsy tissue length and diagnostic efficacy, introducing a new parameter, “unit volume biopsy length”, to optimize clinical practice.</div></div><div><h3>Methods</h3><div>A retrospective analysis was conducted on the clinical data of 301 patients who underwent prostate biopsy. The biopsy tissue length and unit volume biopsy length were compared between patients with positive and negative results, and their impact on the detection rate of prostate cancer was analyzed to obtain the optimal threshold for unit volume biopsy length.</div></div><div><h3>Results</h3><div>Among the 301 patients, 130 (43.19%) had positive results, while 171 had negative results. The median unit volume biopsy length in the positive group was 0.39<!--> <!-->cm/ml, which was significantly higher than that in the negative group (0.28<!--> <!-->cm/ml; <em>P</em>&lt;.05). When the unit volume biopsy length exceeded 0.39<!--> <!-->cm/ml, the detection rate of prostate cancer significantly increased (OR: 2.879, 95% CI: 1.728-4.796), with positive rates of 58.58% and 32.94% in the groups above and below the threshold, respectively (<em>P</em>&lt;.05).</div></div><div><h3>Conclusion</h3><div>Unit volume biopsy length significantly affects the detection rate of prostate cancer. It is recommended that at least 0.39<!--> <!-->cm of biopsy tissue be obtained per milliliter of prostate tissue to ensure adequate screening.</div></div>","PeriodicalId":7145,"journal":{"name":"Actas urologicas espanolas","volume":"49 10","pages":"Article 501862"},"PeriodicalIF":1.2,"publicationDate":"2025-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145623409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Actas urologicas espanolas
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1